Related Experiment Videos
Chemical modification of alpha crystallin
B J Ortwerth1, P R Olesen, K K Sharma
1Mason Institute of Ophthalmology, University of Missouri, Columbia 65212.
Experimental Eye Research
|January 1, 1993
Summary
Modifying calf lens alpha-crystallin lysine residues altered its properties. Introducing negative charges reduced activity, while hydrophobic modifications increased elastase inhibition and antibody reactivity loss.
Area of Science:
- Biochemistry
- Proteomics
- Ophthalmology
Background:
- Alpha-crystallin is a major lens protein.
- Lysine residues are crucial for protein function and modification.
- Understanding modifications aids in studying lens aging and cataract formation.
Purpose of the Study:
- To investigate the impact of chemical modifications on calf lens alpha-crystallin.
- To assess changes in elastase inhibitor activity, molecular size, antibody reactivity, and solubility.
- To correlate structural changes with functional alterations.
Main Methods:
- Isolation and chemical modification of calf lens alpha-crystallin.
- Assays for elastase inhibitor activity and apparent molecular size.
- Quantitative slot blot assay for antibody reactivity.
- Solubility tests at varying salt concentrations.
Main Results:
- Charge-neutral modifications had minor effects; negative charge introduction decreased size and activity.
- Hydrophobic modifications increased elastase inhibitor activity but reduced antibody recognition.
- Fluorescamine modification led to dissociation and increased activity, similar to aged human lens fractions.
- Most modifications significantly reduced antigenic activity, except for charge-neutral ones.
Conclusions:
- Lysine modification significantly impacts alpha-crystallin's biophysical and functional properties.
- Hydrophobic modifications enhance elastase inhibition, suggesting potential roles in lens stability.
- Altered antibody reactivity indicates conformational changes affecting protein recognition.
- These findings provide insights into lens protein behavior during aging and disease.